Bionet (1784) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Bionet (1784) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$85.64 Million ≈ $2.70 Million USD) by net assets (NT$2.24 Billion ≈ $70.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Bionet - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Bionet's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 1784 total liabilities for a breakdown of total debt and financial obligations.

Bionet Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bionet ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TuHURA Biosciences Inc NASDAQ:HURA	-0.265x
Creepy Jar SA WAR:CRJ	0.029x
ELK-Desa Resources Bhd KLSE:5228	0.025x
Menang Corporation (Malaysia) Bhd KLSE:1694	0.058x
Siam Pan Group PCL BK:SPG	0.014x
ReFuels N.V. OL:REFL	N/A
Abra Information Technologies TA:ABRA	0.008x
Bcl Industries Limited NSE:BCLIND	0.021x

Annual Cash Flow Conversion Efficiency for Bionet (2017–2024)

The table below shows the annual cash flow conversion efficiency of Bionet from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Bionet market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$2.40 Billion ≈ $75.48 Million	NT$176.49 Million ≈ $5.56 Million	0.074x	-17.13%
2023-12-31	NT$1.72 Billion ≈ $54.26 Million	NT$153.09 Million ≈ $4.82 Million	0.089x	+24.41%
2022-12-31	NT$1.32 Billion ≈ $41.74 Million	NT$94.65 Million ≈ $2.98 Million	0.071x	+577.37%
2021-12-31	NT$1.32 Billion ≈ $41.45 Million	NT$13.88 Million ≈ $437.23K	0.011x	-81.54%
2020-12-31	NT$1.29 Billion ≈ $40.62 Million	NT$73.66 Million ≈ $2.32 Million	0.057x	+2698.56%
2019-12-31	NT$1.31 Billion ≈ $41.19 Million	NT$2.67 Million ≈ $84.09K	0.002x	+121.09%
2018-12-31	NT$1.34 Billion ≈ $42.22 Million	NT$-12.97 Million ≈ $-408.78K	-0.010x	+46.69%
2017-12-31	NT$1.37 Billion ≈ $43.21 Million	NT$-24.91 Million ≈ $-784.83K	-0.018x	--

About Bionet

TWO:1784 Taiwan Diagnostics & Research

Market Cap

$115.06 Million

NT$3.65 Billion TWD

Market Cap Rank

#18678 Global

#1027 in Taiwan

Share Price

NT$72.60

Change (1 day)

+0.97%

52-Week Range

NT$64.60 - NT$115.50

All Time High

NT$161.50